Kimball Electronics Reports Q3 Results With Double-Digit Sequential Medical Sales Growth

Estimated reading time: 1 minute

Kimball Electronics, Inc. announced financial results for the third quarter ended March 31, 2026.

Commenting on today’s announcement, Richard D. Phillips, Chief Executive Officer, stated, “Results for the third quarter were in line with expectations. Sales increased sequentially compared to Q2, driven by strong growth in our medical vertical market, margins remained solid, and cash from operations was positive for the ninth consecutive quarter. We expect Q4 to be a good finish to the year and we are affirming our guidance for fiscal 2026 with adjusted operating margin estimated to be at the high end of the range.”

Mr. Phillips continued, “As we look forward, the medical CMO continues to be a key part of our strategy and we are making deliberate investments in our capabilities, operating capacity, and commercial focus. When volumes ramp, we expect it to become a meaningful driver of both top line growth and margin expansion. In addition, we continue to focus on inorganic growth as a possible complement to this strategy. We believe this could be a powerful combination for the future of our Company.”

Fiscal Year 2026 Guidance

As part of today’s announcement, the Company affirmed its guidance for fiscal year 2026.

• Net sales in the range of $1,400 - $1,460 million
• Adjusted operating income is estimated to be 4.2% - 4.5% of net sales, with results expected at the high end of the range
• Capital expenditures of $50 - $60 million